UBS Group’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.2M | Buy |
1,965,151
+630,212
| +47% | +$5.85M | ﹤0.01% | 1934 |
|
|
2025
Q1 | $9.79M | Buy |
1,334,939
+458,393
| +52% | +$3.36M | ﹤0.01% | 2380 |
|
|
2024
Q4 | $7.49M | Buy |
876,546
+191,770
| +28% | +$1.64M | ﹤0.01% | 2620 |
|
|
2024
Q3 | $5.96M | Sell |
684,776
-63,957
| -9% | -$556K | ﹤0.01% | 2119 |
|
|
2024
Q2 | $5.12M | Buy |
748,733
+265,227
| +55% | +$1.81M | ﹤0.01% | 2119 |
|
|
2024
Q1 | $4.4M | Buy |
483,506
+392,673
| +432% | +$3.57M | ﹤0.01% | 2303 |
|
|
2023
Q4 | $405K | Buy |
90,833
+37,259
| +70% | +$166K | ﹤0.01% | 4117 |
|
|
2023
Q3 | $168K | Sell |
53,574
-76,377
| -59% | -$240K | ﹤0.01% | 4374 |
|
|
2023
Q2 | $671K | Buy |
129,951
+128,674
| +10,076% | +$664K | ﹤0.01% | 3592 |
|
|
2023
Q1 | $6.73K | Hold |
1,277
| – | – | ﹤0.01% | 6795 |
|
|
2022
Q4 | $3.59K | Buy |
1,277
+277
| +28% | +$778 | ﹤0.01% | 8288 |
|
|
2022
Q3 | $4K | Sell |
1,000
-341,228
| -100% | -$1.36M | ﹤0.01% | 8272 |
|
|
2022
Q2 | $1.38M | Buy |
342,228
+307,344
| +881% | +$1.24M | ﹤0.01% | 2640 |
|
|
2022
Q1 | $173K | Sell |
34,884
-60,006
| -63% | -$298K | ﹤0.01% | 4494 |
|
|
2021
Q4 | $661K | Sell |
94,890
-231,738
| -71% | -$1.61M | ﹤0.01% | 3769 |
|
|
2021
Q3 | $3.27M | Sell |
326,628
-258,165
| -44% | -$2.58M | ﹤0.01% | 2384 |
|
|
2021
Q2 | $8.29M | Buy |
584,793
+33,929
| +6% | +$481K | ﹤0.01% | 1639 |
|
|
2021
Q1 | $9.04M | Sell |
550,864
-69,232
| -11% | -$1.14M | ﹤0.01% | 1511 |
|
|
2020
Q4 | $12.8M | Buy |
620,096
+483,347
| +353% | +$10M | ﹤0.01% | 1252 |
|
|
2020
Q3 | $1.04M | Sell |
136,749
-27,847
| -17% | -$212K | ﹤0.01% | 2892 |
|
|
2020
Q2 | $1.37M | Buy |
164,596
+131,706
| +400% | +$1.1M | ﹤0.01% | 2572 |
|
|
2020
Q1 | $163K | Sell |
32,890
-19,805
| -38% | -$98.2K | ﹤0.01% | 4046 |
|
|
2019
Q4 | $208K | Buy |
52,695
+26,812
| +104% | +$106K | ﹤0.01% | 4579 |
|
|
2019
Q3 | $79K | Buy |
25,883
+25,383
| +5,077% | +$77.5K | ﹤0.01% | 4984 |
|
|
2019
Q2 | $2K | Hold |
500
| – | – | ﹤0.01% | 6746 |
|
|
2019
Q1 | $2K | Sell |
500
-1,423
| -74% | -$5.69K | ﹤0.01% | 6620 |
|
|
2018
Q4 | $8K | Sell |
1,923
-13,613
| -88% | -$56.6K | ﹤0.01% | 6423 |
|
|
2018
Q3 | $107K | Sell |
15,536
-15,734
| -50% | -$108K | ﹤0.01% | 4678 |
|
|
2018
Q2 | $211K | Buy |
31,270
+23,770
| +317% | +$160K | ﹤0.01% | 4059 |
|
|
2018
Q1 | $49K | Buy |
7,500
+1,558
| +26% | +$10.2K | ﹤0.01% | 4882 |
|
|
2017
Q4 | $26K | Sell |
5,942
-2,243
| -27% | -$9.82K | ﹤0.01% | 5390 |
|
|
2017
Q3 | $51K | Buy |
8,185
+3,035
| +59% | +$18.9K | ﹤0.01% | 4899 |
|
|
2017
Q2 | $48K | Sell |
5,150
-2,406
| -32% | -$22.4K | ﹤0.01% | 4758 |
|
|
2017
Q1 | $70K | Buy |
7,556
+4,243
| +128% | +$39.3K | ﹤0.01% | 4411 |
|
|
2016
Q4 | $28K | Sell |
3,313
-2,660
| -45% | -$22.5K | ﹤0.01% | 5358 |
|
|
2016
Q3 | $41K | Buy |
5,973
+2,111
| +55% | +$14.5K | ﹤0.01% | 4812 |
|
|
2016
Q2 | $19K | Buy |
3,862
+2,362
| +157% | +$11.6K | ﹤0.01% | 5469 |
|
|
2016
Q1 | $14K | Sell |
1,500
-4,588
| -75% | -$42.8K | ﹤0.01% | 5610 |
|
|
2015
Q4 | $57K | Buy |
6,088
+2,388
| +65% | +$22.4K | ﹤0.01% | 4652 |
|
|
2015
Q3 | $52K | Buy |
3,700
+3,525
| +2,014% | +$49.5K | ﹤0.01% | 4687 |
|
|
2015
Q2 | $4K | Sell |
175
-603
| -78% | -$13.8K | ﹤0.01% | 6371 |
|
|
2015
Q1 | $33K | Buy |
778
+216
| +38% | +$9.16K | ﹤0.01% | 4983 |
|
|
2014
Q4 | $13K | Buy |
+562
| New | +$13K | ﹤0.01% | 5856 |
|